| Literature DB >> 35527322 |
Cécile Picard1, Nicolas Macagno2,3, Nadège Corradini4, Perrine Marec-Bérard4, Sara Cabet5, Laurent Guibaud5, Loic Viremouneix5, Sébastien Raux6, Franck Chotel6, Nicolas Weinbreck7, Alexandra Meurgey2, Marie Karanian2, Daniel Pissaloux2, Frank Tirode8, Frédérique Dijoud9.
Abstract
Ewing sarcoma (ES) is a highly malignant round cell sarcoma, characterized by gene fusion involving FET (FUS, EWSR1, TAF15) and ETS family genes, respectively. The involvement of the EWSR1 gene has been reported in approximately 90% of cases of ES, with the EWSR1::FLI1 fusion being the most frequent. We report the case of a newborn with a localized soft tissue paravertebral neoplasm diagnosed prenatally. Histopathology and immunophenotype were consistent with a CD99 + , NKX2.2 + undifferentiated round cell sarcoma (URSC); whole-exome RNA-sequencing demonstrated an undescribed in-frame TAF15::ETV4 fusion transcript, while consensus clustering analysis showed high transcriptomic proximity to the ES group. Given clinical context, high tumor chemosensitivity to ES conventional drugs, morphological characteristics, nature of the fusion partners involved, and high transcriptomic proximity to bona fide ESs, this case may represent a new genetic variant of ES.Entities:
Keywords: ETV4; Ewing sarcoma; Pediatric; TAF15; TAF15::ETV4; URSC
Mesh:
Substances:
Year: 2022 PMID: 35527322 DOI: 10.1007/s00428-022-03335-2
Source DB: PubMed Journal: Virchows Arch ISSN: 0945-6317 Impact factor: 4.535